[EN] DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE DIHYDROFUROPYRIDINE EN TANT QU'INHIBITEURS DE LA RHO-KINASE
申请人:[en]CHIESI FARMACEUTICI S.P.A.
公开号:WO2022128843A1
公开(公告)日:2022-06-23
The invention relates to compounds of formula (I) inhibiting Rho Kinase that are dihydrofuropyridine derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. Particularly the compounds of the invention may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).